The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients.

Authors
Publication date
1 January 2021
Publisher

Abstract

Objective. To determine the feasibility of withdrawing canakinumab (CAN) in a large cohort of paediatric patients with colchicine-resistant familial Mediterranean fever (crFMF)

    Similar works

    Full text

    thumbnail-image

    Available Versions

    İstanbul Üniversitesi Açık Erişim Sistemi

    redirect
    oaioai:http://acikerisim.istanbul...
    Last time updated on 19/10/2022

    İstanbul Üniversitesi Açık Erişim Sistemi

    redirect
    oaioai:http://acikerisim.istanbul...
    Last time updated on 19/10/2022